Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aryana Ramezani
Institution:
Isfahan University of Medical Sciences
Observed institution:
Isfahan University of Medical Sciences
ORCID:
0009-0005-1972-9410
Observed ORCID:
0009-0005-1972-9410
OpenAlex ID:
A5111309795
Anti-CD20 therapies for pediatric-onset multiple sclerosis: A systematic review
2024
·
Masoud Etemadifar
, Hosein Nouri
, et al.
·
Multiple Sclerosis and Related Disorders
·
11
Dimethyl Fumarate for Pediatric-Onset Multiple Sclerosis: A Systematic Review
2025
·
Masoud Etemadifar
, Hasan Kaveyee
, et al.
·
Pediatric Neurology
·
6
A comprehensive systematic review of Ibudilast as a neuroprotective therapy for progressive multiple sclerosis
2025
·
Aryana Ramezani
, Jaleh Varshosaz
, et al.
·
Multiple Sclerosis and Related Disorders
·
4
Anti-CD20 versus Dimethyl Fumarate as First-Line Treatment for Pediatric Multiple Sclerosis: A Retrospective Cohort Study
2025
·
Masoud Etemadifar
, Aryana Ramezani
, et al.
·
Neuropediatrics
·
2
Natalizumab for pediatric multiple sclerosis: a systematic review and meta-analysis
2026
·
Yasin Ebne-Ali-Heydari
, Aryana Ramezani
, et al.
·
Therapeutic Advances in Neurological Disorders
·
1
Fingolimod for pediatric multiple sclerosis: The Ped-MS group systematic review and meta-analysis
2026
·
Hasan Kaveyee
, Masoud Etemadifar
, et al.
·
Multiple Sclerosis and Related Disorders
Show more works
View as search
Works count:
6
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type